In the title solvated molecule, C 23 H 26 BrN 9 O 3 S 3 , crystallizes in the triclinic space group P -1, with one molecule and one DMSO molecule in the asymmetric unit. The central chain formed by atoms C8, C10, N4, and N5 adopts an E -configuration, as indicated by a torsion angle of 178.1(3)° around the C10=N4 bond. The crystal structure exhibits N8—H14⋯O3, N9—H19⋯O3, N9—H20⋯N6, C15—H11⋯Br1, C17—H15⋯Br1 intermolecular hydrogen bonding interactions. Hirshfeld surface analysis indicates that the most important contributions to the surface contacts are N⋯H (15.0%), O⋯H (14.1%), C⋯H (14.1%) and H⋯H (34.6%), other minor interactions included Br⋯H (8.8%) and S⋯H (1.0%). Graphical abstract Packing of 4-(2-((2 Z ,5 Z )-2-((( E )-1-(1-(4-bromophenyl)-5-methyl-1 H -1,2,3-triazol-4-yl)ethylidene)hydrazineylidene)-4-methylthiazol-5(2 H )-ylidene)hydrazineyl)benzenesulfonamide DMSO monosolvate formed via N-H…O/N and C-H…Br hydrogen bonds.
No takes yet. Share an insight, caveat, or question.
Khalil et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: